COVID-19 Survivorship Registry

Launched by NYU LANGONE HEALTH · Aug 24, 2020

Keywords

ClinConnect Summary

The COVID-19 Survivorship Registry is a clinical trial designed to study the effects of COVID-19 on the lungs and heart. Researchers want to learn more about how severe COVID-19 can affect a person's breathing and heart function both in the short term and long term. They are looking for participants who have recently tested positive for the virus, whether they were hospitalized, treated in an intensive care unit, or not hospitalized at all. The trial is open to adults aged 18 and older, including those who have recovered from COVID-19 and healthy individuals without a history of the virus.

If you decide to participate, you will be asked to sign a consent form and follow the study's guidelines. The study may involve various assessments, including imaging tests like MRI, which help doctors see how COVID-19 has affected your lungs and heart. It's important to note that certain conditions, like being pregnant or having specific medical devices, may prevent you from participating. This trial aims to provide valuable insights into the lasting effects of COVID-19, helping to improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • have tested positive for SARS-CoV-2 and discharged from the ICU or,
• • have tested positive for SARS-CoV-2 and have been discharged from hospital or,
• • have tested positive for SARS-CoV-2 but was NOT hospitalized
• • ages 18 and over, and
• • competent and willing to sign informed consent and comply to all aspects of the protocol
• • CONTROL Inclusion Criteria
• • No clinical history of COVID-19,
• • No active clinical symptoms indicative of possible COVID-19,
• • Ages 18 and over,
• • competent and willing to sign informed consent and comply to all aspects of the protocol
• Exclusion Criteria:
• • • Participants cannot sign consent
• Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study:
• • Participants who are pregnant or currently trying to get pregnant
• • Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants)
• • Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning.
• • CONTROL Exclusion Criteria
• Patients with any of the following are excluded from as controls:
• • Pace maker
• • Poorly controlled diabetes
• • Poorly controlled Restrictive lung disease
• • Heart failure
• • Parkinson's Disease
• • Hypertension
• • Any diagnosis or history of autonomic neuropathy